Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01847820 · ClinicalTrials.gov registry record
Clinical Evaluation of the AmniSure ROM Test
A clinical trial, sponsored by QIAGEN Gaithersburg.
- Terminated
- Registry status
- 383
- Enrollment target
NCT01847820: Clinical Trial study, sponsored by QIAGEN Gaithersburg.
NCT01847820 is a clinical trial that was terminated before completion, run by QIAGEN Gaithersburg. The registered enrollment target is 383 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01847820 was terminated before completion, sponsored by QIAGEN Gaithersburg.
- TERMINATED
- Registry status
- 383 participants
- Enrollment target
Study Summary
To show that having less qualified personnel (non-Laboratory trained professionals) perform the test yields the same result as if a Laboratory trained professional performed the test.
Primary Outcome
The investigational AmniSure ROM test will be compared to the three standard tests of nitrazine, ferning and pooling to determine rupture of fetal membranes.
Interventions
- DEVICE AmniSure ROM test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 383 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-07 |
Why NCT01847820 stopped before completion
NCT01847820 is an observational study that tracks outcomes without assigning an intervention. The registered 383 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which AmniSure ROM test is the first listed.
NCT01847820 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01847820 about?
NCT01847820 is a clinical study titled "Clinical Evaluation of the AmniSure ROM Test". To show that having less qualified personnel (non-Laboratory trained professionals) perform the test yields the same result as if a Laboratory trained professional performed the test.
What is the current status of trial NCT01847820?
This trial is currently terminated. The enrollment target is 383 participants. The study started on 2013-08. Estimated completion is 2016-07.
What interventions are being tested in trial NCT01847820?
The interventions under investigation include: AmniSure ROM test (DEVICE).
Who is sponsoring clinical trial NCT01847820?
This trial is sponsored by QIAGEN Gaithersburg, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06056830 · 383 participants · Phase 3
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- NCT06277661 · 384 participants · NA
The Mom and Infant Outcomes (MOMI) Study
- NCT06372964 · 384 participants · Phase 3
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- NCT06501040 · 384 participants · NA
Increasing Knowledge and Interest in Cancer Clinical Trials
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia